Feb 18, 2026 | Articles, GLP-1, Peptide Therapy
Peptide therapies, particularly those like GLP-1 agonists (e.g., Ozempic), have become a popular solution for weight loss, improved insulin sensitivity, and overall metabolic health. However, despite their benefits, many people undergoing peptide therapy report...
Feb 18, 2026 | Articles, GLP-1, Peptide Therapy
Quick Summary: To prevent sarcopenia (muscle loss) during GLP-1 therapy (Semaglutide/Tirzepatide), patients must prioritize a “Protein-First” diet of 1.2–1.6g/kg of body weight, engage in resistance training at least twice weekly, and consider supportive...
Feb 18, 2026 | GLP-1, Peptide Therapy
Retatrutide is one of the most aggressive obesity drugs ever tested in clinical trials. In a Phase 2 study, people with obesity lost more than 24% of their starting body weight in under a year at higher doses, a level of weight loss that rivals bariatric surgery...
Feb 18, 2026 | Articles, Peptide Therapy
As peptide therapies become more widely used for weight management and metabolic health, many users are experiencing a common yet often overlooked side effect: constipation and bloating. This is especially true for individuals using GLP-1 agonists like Ozempic and...
Feb 17, 2026 | Articles, Peptide Therapy
If you’ve heard the term peptide therapy and immediately thought, “That sounds either fake, illegal, or reserved for professional athletes,” you’re not alone. Peptides have quietly moved from research labs into clinical medicine, and now into functional and...
Feb 17, 2026 | Articles, Peptide Therapy
As peptide therapies continue to gain popularity, particularly with medications like GLP-1 receptor agonists, a new wave of interest has emerged: people are seeking guidance on how to complement their peptide therapies with proper nutrition to manage side effects and...
